Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
David Lebowitz is an analyst at Citigroup. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 03/23/2025
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 03/04/2025 | PLRX | Buy Now | Pliant Therapeutics | $1.56 | -3.85% | David Lebowitz51% | $4 → $1.5 | Maintains | Neutral | Get Alert |
| 02/28/2025 | NTLA | Buy Now | Intellia Therapeutics | $9.01 | 55.38% | David Lebowitz51% | $12 → $14 | Maintains | Neutral | Get Alert |
| 02/21/2025 | BBIO | Buy Now | BridgeBio Pharma | $34.90 | 40.4% | David Lebowitz51% | $45 → $49 | Maintains | Buy | Get Alert |
| 02/20/2025 | IONS | Buy Now | Ionis Pharmaceuticals | $32.94 | 94.26% | David Lebowitz51% | $67 → $64 | Maintains | Buy | Get Alert |
| 02/12/2025 | EXEL | Buy Now | Exelixis | $37.75 | 19.21% | David Lebowitz51% | $38 → $45 | Maintains | Buy | Get Alert |
| 02/12/2025 | PTCT | Buy Now | PTC Therapeutics | $57.14 | -21.25% | David Lebowitz51% | $32 → $45 | Maintains | Sell | Get Alert |
| 02/11/2025 | INCY | Buy Now | Incyte | $61.92 | 42.12% | David Lebowitz51% | $97 → $88 | Maintains | Buy | Get Alert |
| 02/10/2025 | PLRX | Buy Now | Pliant Therapeutics | $1.56 | 156.41% | David Lebowitz51% | $44 → $4 | Downgrade | Buy → Neutral | Get Alert |
| 02/07/2025 | VKTX | Buy Now | Viking Therapeutics | $28.90 | 31.49% | David Lebowitz51% | → $38 | Initiates | → Neutral | Get Alert |
| 02/07/2025 | CYTK | Buy Now | Cytokinetics | $45.75 | 87.98% | David Lebowitz51% | → $86 | Initiates | → Buy | Get Alert |
| 12/04/2024 | PTCT | Buy Now | PTC Therapeutics | $57.14 | -44% | David Lebowitz51% | $26 → $32 | Maintains | Sell | Get Alert |
| 11/13/2024 | MIRM | Buy Now | Mirum Pharmaceuticals | $45.72 | 48.72% | David Lebowitz51% | $65 → $68 | Maintains | Buy | Get Alert |
| 10/30/2024 | INCY | Buy Now | Incyte | $61.92 | 56.65% | David Lebowitz51% | $92 → $97 | Maintains | Buy | Get Alert |
| 10/25/2024 | NTLA | Buy Now | Intellia Therapeutics | $9.01 | 110.88% | David Lebowitz51% | $25 → $19 | Maintains | Neutral | Get Alert |
| 10/07/2024 | CLDX | Buy Now | Celldex Therapeutics | $19.64 | 256.42% | David Lebowitz51% | → $70 | Initiates | → Buy | Get Alert |
| 09/24/2024 | COGT | Buy Now | Cogent Biosciences | $7.16 | 109.5% | David Lebowitz51% | $13 → $15 | Maintains | Buy | Get Alert |
| 09/17/2024 | ASND | Buy Now | Ascendis Pharma | $159.12 | 30.09% | David Lebowitz51% | $178 → $207 | Maintains | Buy | Get Alert |
| 09/04/2024 | ASND | Buy Now | Ascendis Pharma | $159.12 | 11.86% | David Lebowitz51% | $193 → $178 | Maintains | Buy | Get Alert |
| 07/31/2024 | INCY | Buy Now | Incyte | $61.92 | 42.12% | David Lebowitz51% | $80 → $88 | Maintains | Buy | Get Alert |
| 06/18/2024 | MIRM | Buy Now | Mirum Pharmaceuticals | $45.72 | 39.97% | David Lebowitz51% | $38 → $64 | Maintains | Buy | Get Alert |
| 05/21/2024 | PTCT | Buy Now | PTC Therapeutics | $57.14 | -54.5% | David Lebowitz51% | $18 → $26 | Maintains | Sell | Get Alert |
| 05/10/2024 | NTLA | Buy Now | Intellia Therapeutics | $9.01 | 221.86% | David Lebowitz51% | $31 → $29 | Maintains | Neutral | Get Alert |
| 05/07/2024 | PLRX | Buy Now | Pliant Therapeutics | $1.56 | 2720.51% | David Lebowitz51% | $45 → $44 | Maintains | Buy | Get Alert |
| 05/03/2024 | BPMC | Buy Now | Blueprint Medicines | $88.72 | -14.34% | David Lebowitz51% | $65 → $76 | Maintains | Sell | Get Alert |
| 05/02/2024 | SDGR | Buy Now | Schrodinger | $22.41 | 65.1% | David Lebowitz51% | $39 → $37 | Maintains | Buy | Get Alert |
| 03/06/2024 | MDGL | Buy Now | Madrigal Pharmaceuticals | $341.62 | 11.82% | David Lebowitz51% | → $382 | Initiates | → Buy | Get Alert |
| 03/01/2024 | SDGR | Buy Now | Schrodinger | $22.41 | 74.03% | David Lebowitz51% | $47 → $39 | Maintains | Buy | Get Alert |
| 02/29/2024 | SDGR | Buy Now | Schrodinger | $22.41 | 74.03% | David Lebowitz51% | $47 → $39 | Maintains | Buy | Get Alert |
| 02/26/2024 | COGT | Buy Now | Cogent Biosciences | $7.16 | 81.56% | David Lebowitz51% | $11 → $13 | Maintains | Buy | Get Alert |
| 02/23/2024 | BBIO | Buy Now | BridgeBio Pharma | $34.90 | 31.81% | David Lebowitz51% | $42 → $46 | Maintains | Buy | Get Alert |
| 02/16/2024 | BPMC | Buy Now | Blueprint Medicines | $88.72 | -26.74% | David Lebowitz51% | $54 → $65 | Maintains | Sell | Get Alert |
| 02/14/2024 | INCY | Buy Now | Incyte | $61.92 | 30.81% | David Lebowitz51% | $82 → $81 | Maintains | Buy | Get Alert |
| 02/08/2024 | ASND | Buy Now | Ascendis Pharma | $159.12 | 14.38% | David Lebowitz51% | $146 → $182 | Maintains | Buy | Get Alert |
| 02/08/2024 | COGT | Buy Now | Cogent Biosciences | $7.16 | 53.63% | David Lebowitz51% | → $11 | Initiates | → Buy | Get Alert |
| 12/15/2023 | EXEL | Buy Now | Exelixis | $37.75 | -17.88% | David Lebowitz51% | → $31 | Initiates | → Buy | Get Alert |
| 11/07/2023 | BBIO | Buy Now | BridgeBio Pharma | $34.90 | 20.34% | David Lebowitz51% | → $42 | Initiates | → Buy | Get Alert |
| 08/04/2023 | NTLA | Buy Now | Intellia Therapeutics | $9.01 | 343.95% | David Lebowitz51% | $44 → $40 | Maintains | Neutral | Get Alert |
| 07/31/2023 | IONS | Buy Now | Ionis Pharmaceuticals | $32.94 | 82.12% | David Lebowitz51% | $36 → $60 | Upgrade | Neutral → Buy | Get Alert |
| 07/25/2023 | INCY | Buy Now | Incyte | $61.92 | 32.43% | David Lebowitz51% | → $82 | Initiates | → Buy | Get Alert |
| 06/30/2023 | BMRN | Buy Now | Biomarin Pharmaceutical | $71.90 | 33.52% | David Lebowitz51% | $103 → $96 | Maintains | Neutral | Get Alert |
| 05/08/2023 | NTLA | Buy Now | Intellia Therapeutics | $9.01 | 388.35% | David Lebowitz51% | $39 → $44 | Maintains | Neutral | Get Alert |
| 05/08/2023 | SDGR | Buy Now | Schrodinger | $22.41 | 123.11% | David Lebowitz51% | $52 → $50 | Maintains | Buy | Get Alert |
| 05/04/2023 | IONS | Buy Now | Ionis Pharmaceuticals | $32.94 | 9.27% | David Lebowitz51% | $30 → $36 | Upgrade | Sell → Neutral | Get Alert |
| 04/27/2023 | BMRN | Buy Now | Biomarin Pharmaceutical | $71.90 | 43.25% | David Lebowitz51% | $114 → $103 | Maintains | Neutral | Get Alert |
| 04/05/2023 | ASND | Buy Now | Ascendis Pharma | $159.12 | -8.25% | David Lebowitz51% | $163 → $146 | Maintains | Buy | Get Alert |
| 03/13/2023 | PLRX | Buy Now | Pliant Therapeutics | $1.56 | 3105.13% | David Lebowitz51% | $55 → $50 | Maintains | Buy | Get Alert |
| 02/21/2023 | BMRN | Buy Now | Biomarin Pharmaceutical | $71.90 | 61.34% | David Lebowitz51% | → $116 | Initiates | → Neutral | Get Alert |
| 01/31/2023 | SDGR | Buy Now | Schrodinger | $22.41 | 127.58% | David Lebowitz51% | $48 → $51 | Maintains | Buy | Get Alert |
| 01/24/2023 | NTLA | Buy Now | Intellia Therapeutics | $9.01 | 332.85% | David Lebowitz51% | $48 → $39 | Upgrade | Sell → Neutral | Get Alert |
| 01/24/2023 | PLRX | Buy Now | Pliant Therapeutics | $1.56 | 3425.64% | David Lebowitz51% | $36 → $55 | Maintains | Buy | Get Alert |
| 11/10/2022 | MIRM | Buy Now | Mirum Pharmaceuticals | $45.72 | -25.64% | David Lebowitz51% | $38 → $34 | Maintains | Buy | Get Alert |
| 11/10/2022 | IONS | Buy Now | Ionis Pharmaceuticals | $32.94 | -5.9% | David Lebowitz51% | $28 → $31 | Maintains | Sell | Get Alert |
| 11/03/2022 | ASND | Buy Now | Ascendis Pharma | $159.12 | 2.44% | David Lebowitz51% | $157 → $163 | Maintains | Buy | Get Alert |
| 09/01/2022 | MIRM | Buy Now | Mirum Pharmaceuticals | $45.72 | -16.89% | David Lebowitz51% | → $38 | Initiates | → Buy | Get Alert |
| 09/01/2022 | PTCT | Buy Now | PTC Therapeutics | $57.14 | 22.51% | David Lebowitz51% | → $70 | Initiates | → Buy | Get Alert |
| 09/01/2022 | NTLA | Buy Now | Intellia Therapeutics | $9.01 | 454.94% | David Lebowitz51% | → $50 | Initiates | → Sell | Get Alert |
| 09/01/2022 | PLRX | Buy Now | Pliant Therapeutics | $1.56 | 2207.69% | David Lebowitz51% | → $36 | Initiates | → Buy | Get Alert |
| 08/10/2022 | IONS | Buy Now | Ionis Pharmaceuticals | $32.94 | -15.01% | David Lebowitz51% | $26 → $28 | Maintains | Sell | Get Alert |
| 07/15/2022 | IMRX | Buy Now | Immuneering | $1.82 | 560.03% | David Lebowitz51% | $18 → $12 | Maintains | Equal-Weight | Get Alert |
| 07/15/2022 | ALNY | Buy Now | Alnylam Pharmaceuticals | $283.34 | -42.12% | David Lebowitz51% | $170 → $164 | Maintains | Equal-Weight | Get Alert |
| 06/10/2022 | BPMC | Buy Now | Blueprint Medicines | $88.72 | -53.79% | David Lebowitz51% | $68 → $41 | Downgrade | Neutral → Sell | Get Alert |
| 06/07/2022 | ARQT | Buy Now | Arcutis Biotherapeutics | $16.99 | 129.55% | David Lebowitz51% | $36 → $39 | Maintains | Overweight | Get Alert |
| 05/12/2022 | ASND | Buy Now | Ascendis Pharma | $159.12 | -0.7% | David Lebowitz51% | $187 → $158 | Maintains | Buy | Get Alert |
| 05/10/2022 | ARQT | Buy Now | Arcutis Biotherapeutics | $16.99 | 111.89% | David Lebowitz51% | $37 → $36 | Maintains | Overweight | Get Alert |
| 05/09/2022 | IONS | Buy Now | Ionis Pharmaceuticals | $32.94 | -8.94% | David Lebowitz51% | $31 → $30 | Maintains | Underweight | Get Alert |
| 04/29/2022 | ALNY | Buy Now | Alnylam Pharmaceuticals | $283.34 | -25.53% | David Lebowitz51% | $223 → $211 | Maintains | Buy | Get Alert |
| 04/13/2022 | BPMC | Buy Now | Blueprint Medicines | $88.72 | -23.35% | David Lebowitz51% | $71 → $68 | Maintains | Neutral | Get Alert |
| 03/15/2022 | ASND | Buy Now | Ascendis Pharma | $159.12 | 23.81% | David Lebowitz51% | $180 → $197 | Maintains | Overweight | Get Alert |
| 03/07/2022 | ASND | Buy Now | Ascendis Pharma | $159.12 | 13.12% | David Lebowitz51% | $197 → $180 | Maintains | Overweight | Get Alert |
| 03/02/2022 | ARQT | Buy Now | Arcutis Biotherapeutics | $16.99 | 117.78% | David Lebowitz51% | $35 → $37 | Maintains | Overweight | Get Alert |
| 03/01/2022 | ALNY | Buy Now | Alnylam Pharmaceuticals | $283.34 | -21.3% | David Lebowitz51% | → $223 | Initiates | → Buy | Get Alert |
| 03/01/2022 | SDGR | Buy Now | Schrodinger | $22.41 | 145.43% | David Lebowitz51% | → $55 | Initiates | → Buy | Get Alert |
| 03/01/2022 | IONS | Buy Now | Ionis Pharmaceuticals | $32.94 | -21.08% | David Lebowitz51% | → $26 | Initiates | → Sell | Get Alert |
| 03/01/2022 | BPMC | Buy Now | Blueprint Medicines | $88.72 | — | David Lebowitz51% | — | Initiates | → Neutral | Get Alert |
| 03/01/2022 | ASND | Buy Now | Ascendis Pharma | $159.12 | 17.52% | David Lebowitz51% | → $187 | Initiates | → Buy | Get Alert |
| 02/23/2022 | ALNY | Buy Now | Alnylam Pharmaceuticals | $283.34 | -25.88% | David Lebowitz51% | $215 → $210 | Maintains | Overweight | Get Alert |
| 01/18/2022 | ALNY | Buy Now | Alnylam Pharmaceuticals | $283.34 | -24.12% | David Lebowitz51% | $226 → $215 | Maintains | Overweight | Get Alert |
| 11/19/2021 | ARQT | Buy Now | Arcutis Biotherapeutics | $16.99 | 106% | David Lebowitz51% | $50 → $35 | Maintains | Overweight | Get Alert |
| 10/29/2021 | ALNY | Buy Now | Alnylam Pharmaceuticals | $283.34 | -20.24% | David Lebowitz51% | $242 → $226 | Maintains | Overweight | Get Alert |
| 10/12/2021 | SNDX | Buy Now | Syndax Pharmaceuticals | $13.89 | 51.19% | David Lebowitz51% | $20 → $21 | Maintains | Equal-Weight | Get Alert |
| 10/12/2021 | KPTI | Buy Now | Karyopharm Therapeutics | $6.42 | 320.56% | David Lebowitz51% | $435 → $405 | Maintains | Overweight | Get Alert |
| 10/12/2021 | IRWD | Buy Now | Ironwood Pharmaceuticals | $1.41 | 892.91% | David Lebowitz51% | $13 → $14 | Maintains | Equal-Weight | Get Alert |
| 10/12/2021 | IONS | Buy Now | Ionis Pharmaceuticals | $32.94 | -5.9% | David Lebowitz51% | $33 → $31 | Maintains | Underweight | Get Alert |
| 10/12/2021 | AVRO | Buy Now | Avrobio | — | — | David Lebowitz51% | $324 → $300 | Maintains | Overweight | Get Alert |
| 10/12/2021 | ALNY | Buy Now | Alnylam Pharmaceuticals | $283.34 | -14.59% | David Lebowitz51% | $234 → $242 | Maintains | Overweight | Get Alert |
| 09/01/2021 | SDGR | Buy Now | Schrodinger | $22.41 | 265.91% | David Lebowitz51% | → $82 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 08/26/2021 | ASND | Buy Now | Ascendis Pharma | $159.12 | 28.2% | David Lebowitz51% | $197 → $204 | Maintains | Overweight | Get Alert |
| 08/24/2021 | IMRX | Buy Now | Immuneering | $1.82 | 2045.1% | David Lebowitz51% | → $39 | Initiates | → Equal-Weight | Get Alert |
| 08/10/2021 | EPZM | Buy Now | Epizyme | — | — | David Lebowitz51% | $10 → $5 | Downgrade | Equal-Weight → Underweight | Get Alert |
| 07/16/2021 | IRWD | Buy Now | Ironwood Pharmaceuticals | $1.41 | 751.06% | David Lebowitz51% | $11 → $12 | Maintains | Equal-Weight | Get Alert |
| 07/16/2021 | IONS | Buy Now | Ionis Pharmaceuticals | $32.94 | 0.17% | David Lebowitz51% | $35 → $33 | Maintains | Underweight | Get Alert |
| 07/16/2021 | AVRO | Buy Now | Avrobio | — | — | David Lebowitz51% | $372 → $348 | Maintains | Overweight | Get Alert |
| 07/16/2021 | ARQT | Buy Now | Arcutis Biotherapeutics | $16.99 | 194.29% | David Lebowitz51% | $52 → $50 | Maintains | Overweight | Get Alert |
| 06/14/2021 | ASND | Buy Now | Ascendis Pharma | $159.12 | 23.81% | David Lebowitz51% | $201 → $197 | Maintains | Overweight | Get Alert |
| 05/28/2021 | ASND | Buy Now | Ascendis Pharma | $159.12 | 26.32% | David Lebowitz51% | $199 → $201 | Maintains | Overweight | Get Alert |
| 05/27/2021 | ARQT | Buy Now | Arcutis Biotherapeutics | $16.99 | 206.06% | David Lebowitz51% | → $52 | Initiates | → Overweight | Get Alert |
| 05/12/2021 | SNDX | Buy Now | Syndax Pharmaceuticals | $13.89 | 43.99% | David Lebowitz51% | $25 → $20 | Maintains | Equal-Weight | Get Alert |
| 12/07/2020 | SNDX | Buy Now | Syndax Pharmaceuticals | $13.89 | 79.99% | David Lebowitz51% | $17 → $25 | Maintains | Equal-Weight | Get Alert |
| 11/13/2020 | SDGR | Buy Now | Schrodinger | $22.41 | 297.14% | David Lebowitz51% | $90 → $89 | Maintains | Equal-Weight | Get Alert |
| 11/09/2020 | EPZM | Buy Now | Epizyme | — | — | David Lebowitz51% | $29 → $27 | Maintains | Overweight | Get Alert |
| 11/05/2020 | IONS | Buy Now | Ionis Pharmaceuticals | $32.94 | 48.73% | David Lebowitz51% | $50 → $49 | Maintains | Underweight | Get Alert |
| 11/04/2020 | SNDX | Buy Now | Syndax Pharmaceuticals | $13.89 | 22.39% | David Lebowitz51% | $16 → $17 | Maintains | Equal-Weight | Get Alert |
| 10/13/2020 | SDGR | Buy Now | Schrodinger | $22.41 | 301.61% | David Lebowitz51% | $93 → $90 | Maintains | Equal-Weight | Get Alert |
| 10/13/2020 | IONS | Buy Now | Ionis Pharmaceuticals | $32.94 | 51.77% | David Lebowitz51% | $54 → $50 | Maintains | Underweight | Get Alert |
| 08/06/2020 | IONS | Buy Now | Ionis Pharmaceuticals | $32.94 | 63.91% | David Lebowitz51% | $56 → $54 | Maintains | Underweight | Get Alert |
| 06/01/2020 | SNDX | Buy Now | Syndax Pharmaceuticals | $13.89 | 15.19% | David Lebowitz51% | $22 → $16 | Maintains | Equal-Weight | Get Alert |
| 05/29/2020 | SNDX | Buy Now | Syndax Pharmaceuticals | $13.89 | 15.19% | David Lebowitz51% | $22 → $16 | Maintains | Equal-Weight | Get Alert |
| 05/21/2020 | SNDX | Buy Now | Syndax Pharmaceuticals | $13.89 | 58.39% | David Lebowitz51% | $10 → $22 | Maintains | Equal-Weight | Get Alert |
| 03/11/2020 | SNDX | Buy Now | Syndax Pharmaceuticals | $13.89 | -28.01% | David Lebowitz51% | $8 → $10 | Maintains | Equal-Weight | Get Alert |
| 10/29/2018 | SNDX | Buy Now | Syndax Pharmaceuticals | $13.89 | — | David Lebowitz51% | — | Downgrade | Overweight → Equal-Weight | Get Alert |
| 03/14/2018 | SNDX | Buy Now | Syndax Pharmaceuticals | $13.89 | 72.79% | David Lebowitz51% | $25 → $24 | Maintains | Overweight | Get Alert |
| 03/28/2016 | SNDX | Buy Now | Syndax Pharmaceuticals | $13.89 | 58.39% | David Lebowitz51% | → $22 | Initiates | → Overweight | Get Alert |
